Covered recipient · General Payments record
ANEES QUYYUMI
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2018–2024
$109.57
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Education | $74.41 | 13 |
| Food and Beverage | $24.33 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Retrophin, Inc. | $74.41 | 13 |
| Bayer HealthCare Pharmaceuticals Inc. | $24.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $24.33 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086232218 | CMS |
| Travere Therapeutics, Inc. | $3.08 | 01/31/2024 | Education | Undisputed | 01/23/2026 | 1149919138 | CMS |
| Travere Therapeutics, Inc. | $16.89 | 01/31/2024 | Education | Undisputed | 01/23/2026 | 1149919166 | CMS |
| Travere Therapeutics, Inc. | $3.08 | 03/25/2024 | Education | Undisputed | 01/23/2026 | 1149919142 | CMS |
| Travere Therapeutics, Inc. | $16.89 | 03/25/2024 | Education | Undisputed | 01/23/2026 | 1149919170 | CMS |
| Travere Therapeutics, Inc. | $3.08 | 05/02/2024 | Education | Undisputed | 01/23/2026 | 1149919146 | CMS |
| Travere Therapeutics, Inc. | $0.37 | 07/10/2024 | Education | Undisputed | 01/23/2026 | 1149919126 | CMS |
| Travere Therapeutics, Inc. | $3.08 | 07/10/2024 | Education | Undisputed | 01/23/2026 | 1149919150 | CMS |
| Travere Therapeutics, Inc. | $16.89 | 07/10/2024 | Education | Undisputed | 01/23/2026 | 1149919174 | CMS |
| Travere Therapeutics, Inc. | $0.37 | 08/13/2024 | Education | Undisputed | 01/23/2026 | 1149919130 | CMS |
| Travere Therapeutics, Inc. | $3.08 | 08/13/2024 | Education | Undisputed | 01/23/2026 | 1149919154 | CMS |
| Travere Therapeutics, Inc. | $0.37 | 09/16/2024 | Education | Undisputed | 01/23/2026 | 1149919134 | CMS |
| Travere Therapeutics, Inc. | $3.08 | 09/16/2024 | Education | Undisputed | 01/23/2026 | 1149919158 | CMS |
| Travere Therapeutics, Inc. | $4.15 | 09/16/2024 | Education | Undisputed | 01/23/2026 | 1149919162 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.